Tierney David S
Insider CIK 1292636 · CPRX Director · KMPH Director · BPMX Pres and CEO, Director · BJCT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 30,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 33,500 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 5,468 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,894 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 1,414 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 18,115 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 23,248 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 29,524 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 15,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 20,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 383,314 | $31.50 | $12.07M | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 178,163 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 1,334 | — | $0 | 383,314 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 179,497 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-08 | 2025-12-10 | 1,413 | — | $0 | 381,980 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 180,910 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 947 | — | $0 | 380,567 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 5,468 | — | $0 | 181,857 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 18,115 | — | $0 | 176,389 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-08-27 | 2025-08-28 | 50,000 | — | $0 | 158,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-08-27 | 2025-08-28 | 50,000 | $2.24 | $112.0K | 405,620 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-08-27 | 2025-08-28 | 26,000 | $20.20 | $525.2K | 379,620 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 208,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 355,620 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 212,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 351,620 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 213,607 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 350,287 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 2,841 | — | $0 | 215,020 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 23,248 | — | $0 | 212,179 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-08-22 | 2024-08-23 | 15,000 | — | $0 | 188,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-08-21 | 2024-08-23 | 15,000 | $4.01 | $60.1K | 363,874 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-08-21 | 2024-08-23 | 15,000 | $20.10 | $301.5K | 348,874 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-04-08 | 2024-04-10 | 25,000 | — | $0 | 203,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-04-08 | 2024-04-10 | 25,000 | $4.01 | $100.3K | 373,874 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 25,000 | $15.68 | $392.0K | 348,874 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 228,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 348,874 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-01-02 | 2024-01-03 | 10,000 | — | $0 | 232,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-01-02 | 2024-01-03 | 10,000 | $1.13 | $11.3K | 344,874 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 242,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 334,874 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-12 | 2023-12-14 | 50,000 | — | $0 | 244,264 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-12 | 2023-12-14 | 50,000 | $1.13 | $56.5K | 383,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-12-12 | 2023-12-14 | 50,000 | $13.33 | $666.5K | 333,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 29,524 | — | $0 | 290,024 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 4,240 | — | $0 | 294,264 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-05-11 | 2023-05-12 | 20,000 | — | $0 | 260,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-05-11 | 2023-05-12 | 20,000 | $0.79 | $15.8K | 333,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-04-05 | 2023-04-07 | 30,000 | — | $0 | 280,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-04-05 | 2023-04-07 | 30,000 | $0.79 | $23.7K | 343,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-04-05 | 2023-04-07 | 30,000 | $16.83 | $504.9K | 313,541 | SEC↗ |
| ZVRA ZEVRA THERAPEUTICS, INC. | P Buy | 2023-03-09 | 2023-03-13 | 5,000 | $4.15 | $20.8K | 10,835 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 310,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 313,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 15,000 | — | $0 | 310,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 4,000 | — | $0 | 314,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-12-06 | 2022-12-08 | 1,334 | — | $0 | 295,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-12-06 | 2022-12-08 | 1,334 | — | $0 | 309,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-22 | 2022-08-23 | 20,000 | — | $0 | 296,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-22 | 2022-08-23 | 20,000 | $14.16 | $283.2K | 308,207 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-22 | 2022-08-23 | 20,000 | $2.53 | $50.6K | 328,207 | SEC↗ |
| KMPH KEMPHARM, INC | A Award deriv | 2022-06-28 | 2022-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KMPH KEMPHARM, INC | P Buy | 2022-05-25 | 2022-05-26 | 2,000 | $4.39 | $8.8K | 5,835 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-05-20 | 2022-05-24 | 20,000 | — | $0 | 252,333 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-05-20 | 2022-05-24 | 20,000 | — | $0 | 308,207 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-05-20 | 2022-05-24 | 20,000 | $2.53 | $50.6K | 328,207 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 12,000 | — | $0 | 336,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 20,000 | — | $0 | 324,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-12-03 | 2021-12-06 | 1,333 | — | $0 | 304,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-12-03 | 2021-12-06 | 1,333 | — | $0 | 308,207 | SEC↗ |
| KMPH KEMPHARM, INC | P Buy | 2021-11-30 | 2021-11-30 | 2,000 | $7.79 | $15.6K | 3,835 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-08-13 | 2021-08-17 | 50,000 | — | $0 | 306,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2021-08-13 | 2021-08-17 | 50,000 | $6.08 | $304.0K | 306,874 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-08-13 | 2021-08-17 | 50,000 | $3.12 | $156.0K | 356,874 | SEC↗ |
| KMPH KEMPHARM, INC | A Award deriv | 2021-06-17 | 2021-06-21 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 30,000 | — | $0 | 356,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2020-12-22 | 2020-12-23 | 1,333 | — | $0 | 326,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2020-12-22 | 2020-12-23 | 1,333 | — | $0 | 306,874 | SEC↗ |
| KMPH KEMPHARM, INC | P Buy | 2020-08-18 | 2020-08-18 | 2,500 | $0.64 | $1.6K | 21,872 | SEC↗ |
| KMPH KEMPHARM, INC | P Buy | 2020-08-18 | 2020-08-18 | 1,000 | $0.67 | $670 | 29,372 | SEC↗ |
| KMPH KEMPHARM, INC | P Buy | 2020-08-18 | 2020-08-18 | 4,500 | $0.66 | $3.0K | 28,372 | SEC↗ |
| KMPH KEMPHARM, INC | P Buy | 2020-08-18 | 2020-08-18 | 2,000 | $0.65 | $1.3K | 23,872 | SEC↗ |
| KMPH KEMPHARM, INC | A Award deriv | 2020-06-19 | 2020-06-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 4,000 | — | $0 | 327,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 33,500 | — | $0 | 323,500 | SEC↗ |
| KMPH KEMPHARM, INC | A Award | 2019-06-30 | 2019-07-02 | 6,428 | — | $0 | 19,372 | SEC↗ |
| BPMX BioPharmX Corp | A Award deriv | 2019-06-12 | 2019-06-14 | 360,000 | $0.84 | $302.4K | 360,000 | SEC↗ |
| KMPH KEMPHARM, INC | A Award | 2019-05-10 | 2019-05-14 | 6,944 | — | $0 | 12,944 | SEC↗ |
| KMPH KEMPHARM, INC | A Award deriv | 2019-04-24 | 2019-04-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 25,000 | — | $0 | 265,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 25,000 | — | $0 | 290,000 | SEC↗ |
| BPMX BioPharmX Corp | P Buy | 2018-09-19 | 2018-09-20 | 100,000 | $0.20 | $20.0K | 7,500,000 | SEC↗ |
| BPMX BioPharmX Corp | A Award deriv | 2018-09-11 | 2018-09-13 | 7,400,000 | $0.22 | $1.63M | 7,400,000 | SEC↗ |
| KMPH KEMPHARM, INC | A Award deriv | 2018-05-22 | 2018-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 20,000 | — | $0 | 220,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 20,000 | — | $0 | 240,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2017-11-09 | 2017-11-13 | 50,000 | — | $0 | 145,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2017-11-09 | 2017-11-13 | 7,860 | — | $0 | 305,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2017-11-09 | 2017-11-13 | 50,000 | $0.47 | $23.5K | 313,401 | SEC↗ |
| KMPH KEMPHARM, INC | A Award deriv | 2017-05-23 | 2017-05-24 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KMPH KEMPHARM, INC | P Buy | 2017-03-20 | 2017-03-21 | 1,000 | $4.20 | $4.2K | 6,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 30,000 | — | $0 | 250,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 30,000 | — | $0 | 220,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 25,000 | — | $0 | 220,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 25,000 | — | $0 | 195,000 | SEC↗ |
| KMPH KEMPHARM, INC | A Award deriv | 2016-05-24 | 2016-05-26 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 20,000 | — | $0 | 170,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 20,000 | — | $0 | 150,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2015-10-27 | 2015-10-29 | 30,000 | — | $0 | 105,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2015-10-27 | 2015-10-29 | 10,000 | — | $0 | 263,401 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2015-10-27 | 2015-10-29 | 30,000 | $1.09 | $32.7K | 273,401 | SEC↗ |
| KMPH KEMPHARM, INC | A Award deriv | 2015-08-25 | 2015-08-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KMPH KEMPHARM, INC | P Buy | 2015-04-21 | 2015-05-12 | 5,000 | $11.00 | $55.0K | 5,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise deriv | 2014-10-16 | 2014-10-20 | 30,000 | — | $0 | 160,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise | 2014-10-16 | 2014-10-20 | 30,000 | $0.90 | $27.0K | 243,401 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 25,000 | — | $0 | 165,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 25,000 | — | $0 | 190,000 | SEC↗ |
| BJCT BIOJECT MEDICAL TECHNOLOGI | C Conversion deriv | 2014-04-30 | 2014-06-03 | 78,400 | $0.75 | $58.8K | 0 | SEC↗ |
| BJCT BIOJECT MEDICAL TECHNOLOGI | C Conversion | 2014-04-30 | 2014-06-03 | 78,400 | $0.75 | $58.8K | 156,400 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2013-10-23 | 2013-10-25 | 8,000 | $2.03 | $16.2K | 213,401 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 50,000 | — | $0 | 161,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-05-29 | 2012-05-31 | 20,000 | $0.58 | $11.6K | 205,401 | SEC↗ |